Centre Approves Biotech Vax Production Facility At Ankleshwar

India's Covid vaccination coverage has crossed 51 crores cumulatively.

The Centre on Tuesday approved the Bharat Biotech's Covaxin manufacturing and production facilities at Ankleshwar in Gujarat. This move is expected to boost the massive vaccination drive against Covid-19 in India. It will also help to meet the vaccine targets to jab all citizens.

The union health minister said in a tweet that following PM Midi's vision, it will increase vaccine availability and accelerate the world's largest vaccine drive.